These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25256874)

  • 1. Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome.
    Bouzas IC; Cader SA; Leão L; Kuschnir MC; Braga C
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):335-41. PubMed ID: 25256874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.
    Panidis D; Tziomalos K; Chatzis P; Papadakis E; Delkos D; Tsourdi EA; Kandaraki EA; Katsikis I
    Eur J Endocrinol; 2013 Feb; 168(2):145-52. PubMed ID: 23109645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome.
    Elting MW; Korsen TJ; Schoemaker J
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.
    Bhattacharya SM; Jha A
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1303-7. PubMed ID: 21535308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome.
    Li X; Yang J; Blockeel C; Lin M; Tian X; Wu H; Cao Y; Deng L; Zhou X; Xie J; Hu Y; Chen X
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1606-1614. PubMed ID: 38715377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic profile in women with polycystic ovary syndrome across adult life.
    Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
    Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
    Robinson S; Kiddy D; Gelding SV; Willis D; Niththyananthan R; Bush A; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):351-5. PubMed ID: 8222298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW; Maciel GAR
    Arch Gynecol Obstet; 2021 Mar; 303(3):739-749. PubMed ID: 33201375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.